EGFR and HER2 genomic gain in recurrent non-small cell lung cancer after surgery: impact on outcome to treatment with gefitinib and association with EGFR and KRAS mutations in a Japanese cohort (Q36048238)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
EGFR and HER2 genomic gain in recurrent non-small cell lung cancer after surgery: impact on outcome to treatment with gefitinib and association with EGFR and KRAS mutations in a Japanese cohort
scientific article

    Statements

    EGFR and HER2 genomic gain in recurrent non-small cell lung cancer after surgery: impact on outcome to treatment with gefitinib and association with EGFR and KRAS mutations in a Japanese cohort (English)
    Tetsuya Mitsudomi
    Yashushi Yatabe
    Takayuki Kosaka
    Eiji Nakajima
    Ana Carolina Xavier
    Margaret Skokan
    Chan Zeng
    Wilbur A Franklin
    Paul A Bunn
    1 March 2009
    318-325

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit